Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
09 Nov 2023, 16:35:45 UTC
Prior SEC filing
20 Jun 2023
Next SEC filing
15 Dec 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Matrix Capital Management Company, LP, by: /s/ David E. Goel, its Managing General Partner

Key filing fact

Matrix Capital Management Company, LP filed Form 4 for Aura Biosciences, Inc. (AURA) on 09 Nov 2023.

Key facts

  • This page summarizes Matrix Capital Management Company, LP's Form 4 filing for Aura Biosciences, Inc. (AURA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 09 Nov 2023, 16:35.

Change

  • Previous filing in this sequence was filed on 20 Jun 2023.
  • Current net transaction value: +$14,040,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AURA transaction

Common Stock, par value $0.00001 per share (Common Stock)

Purchase

Transaction value
$14,040,000
Shares
+1,560,000
Change %
+29%
Price
$9.00
Shares after
6,922,870
Date
09 Nov 2023
Ownership
See footnotes
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The securities reported herein are held by Matrix Capital Management Master Fund, LP (the "Matrix Fund"). Matrix Capital Management Company, LP (the "Investment Manager"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel ("Mr. Goel", and together with the Investment Manager, the "Reporting Persons"), serves as the Managing General Partner of the Investment Manager.

Footnote F2

The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .